Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer DS Matassa, MR Amoroso, H Lu, R Avolio, D Arzeni, C Procaccini, ... Cell Death & Differentiation 23 (9), 1542-1554, 2016 | 182 | 2016 |
A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic-and molecular-phenotypes of epithelial ovarian cancer H Lu, M Arshad, A Thornton, G Avesani, P Cunnea, ED Curry, F Kanavati, ... Nature communications 10 (1), 764, 2019 | 172 | 2019 |
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer TG Hopkins, M Mura, HA Al-Ashtal, RM Lahr, N Abd-Latip, K Sweeney, ... Nucleic acids research 44 (3), 1227-1246, 2016 | 169 | 2016 |
Radiomics and artificial intelligence for precision medicine in lung cancer treatment M Chen, SJ Copley, P Viola, H Lu, EO Aboagye Seminars in cancer biology 93, 97-113, 2023 | 75 | 2023 |
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung … MA Arshad, A Thornton, H Lu, H Tam, K Wallitt, N Rodgers, A Scarsbrook, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 455-466, 2019 | 75 | 2019 |
TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial–mesenchymal transition MR Amoroso, DS Matassa, I Agliarulo, R Avolio, H Lu, L Sisinni, G Lettini, ... Cell Death & Disease 7 (12), e2522-e2522, 2016 | 50 | 2016 |
Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival G Avesani, M Arshad, H Lu, C Fotopoulou, F Cannone, R Melotti, ... La radiologia medica 125, 770-776, 2020 | 47 | 2020 |
A novel radiogenomics biomarker for predicting treatment response and pneumotoxicity from programmed cell death protein or ligand-1 inhibition immunotherapy in NSCLC M Chen, H Lu, SJ Copley, Y Han, A Logan, P Viola, A Cortellini, DJ Pinato, ... Journal of Thoracic Oncology 18 (6), 718-730, 2023 | 33 | 2023 |
Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma S Antonowicz, Z Bodai, T Wiggins, SR Markar, PR Boshier, YM Goh, ... Nature Communications 12 (1), 1454, 2021 | 29 | 2021 |
A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease M Inglese, N Patel, K Linton-Reid, F Loreto, Z Win, RJ Perry, C Carswell, ... Communications medicine 2 (1), 70, 2022 | 27 | 2022 |
Anti-tumorigenic and platinum-sensitizing effects of apolipoprotein A1 and apolipoprotein A1 mimetic peptides in ovarian cancer AT Marinho, H Lu, SA Pereira, E Monteiro, H Gabra, C Recchi Frontiers in pharmacology 9, 1524, 2019 | 26 | 2019 |
Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC) C Fotopoulou, A Rockall, H Lu, P Lee, G Avesani, L Russo, F Petta, ... British journal of cancer 126 (7), 1047-1054, 2022 | 22 | 2022 |
Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer H Lu, H Lou, G Wengert, R Paudel, N Patel, S Desai, B Crum, ... Cell Reports Medicine 4 (7), 2023 | 20 | 2023 |
Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer H Lu, P Cunnea, K Nixon, N Rinne, EO Aboagye, C Fotopoulou British journal of cancer 124 (7), 1286-1293, 2021 | 17 | 2021 |
The Oxford classic links epithelial-to-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers Z Hu, P Cunnea, Z Zhong, H Lu, OI Osagie, L Campo, M Artibani, K Nixon, ... Clinical Cancer Research 27 (5), 1570-1579, 2021 | 17 | 2021 |
Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions JR Birtley, M Alomary, E Zanini, J Antony, Z Maben, GC Weaver, ... Nature communications 10 (1), 3134, 2019 | 17 | 2019 |
The scaffold protein Ajuba suppresses CdGAP activity in epithelia to maintain stable cell-cell contacts JJ McCormack, S Bruche, ABD Ouadda, H Ishii, H Lu, A Garcia-Cattaneo, ... Scientific Reports 7 (1), 9249, 2017 | 16 | 2017 |
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression M Natoli, J Gallon, H Lu, A Amgheib, DJ Pinato, FA Mauri, T Marafioti, ... Journal for ImmunoTherapy of Cancer 9 (1), 2021 | 15 | 2021 |
Discriminatory changes in circulating metabolites as a predictor of hepatocellular cancer in patients with metabolic (Dysfunction) associated fatty liver disease H Lu, J George, M Eslam, A Villanueva, L Bolondi, HL Reeves, M McCain, ... Liver Cancer 12 (1), 19-31, 2023 | 14 | 2023 |
Monitoring response to transarterial chemoembolization in hepatocellular carcinoma using 18F-fluorothymidine PET R Sharma, M Inglese, S Dubash, H Lu, DJ Pinato, C Sanghera, N Patel, ... Journal of Nuclear Medicine 61 (12), 1743-1748, 2020 | 11 | 2020 |